Clinical trial / 2009
High-dose isoflavones improved quality-of-life subscales in post-menopausal women without significantly altering cognition.
A 12-week randomized trial evaluated 93 post-menopausal women receiving either 20 g soy protein with 160 mg total isoflavones or a taste-matched whole milk protein placebo. Eighty-four women completed the study. Women taking isoflavones experienced significant improvements in all four Menopause-specific Quality of Life subscales (vasomotor, psychosexual, physical, and sexual), with no changes in the placebo group. No significant changes occurred within groups for cognition, serum androgens, or plasma lipids, though a group-by-time interaction showed significantly lower total testosterone and HDL levels in the isoflavone group versus placebo at study end.
- Study type
- Double-blind randomized placebo-controlled trial
- Who was studied
- 93 healthy, ambulatory post-menopausal women (mean age 56 years)
- What was measured
- Menopause-specific quality of life, cognitive function, androgens, gonadotropins, SHBG, and fasting lipids
THE PAPER
Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.
Basaria S, Wisniewski A, Dupree K, Bruno T, Song MY, Yao F, Ojumu A, John M, Dobs AS. J Endocrinol Invest, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.